Showing results (1311-1320 of 1,329) with videos related to
Sort By:
Pageof 133
Oncoimmunology|November 15, 2021
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanomaMichael G White, Robert Szczepaniak Sloane, Russell G Witt, et al.Science (New York, N.Y.)|October 30, 2016
Gravity field of the Orientale basin from the Gravity Recovery and Interior Laboratory MissionMaria T Zuber, David E Smith, Gregory A Neumann, et al.Med (New York, N.Y.)|March 5, 2021
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and InfectionJoe N Frost, Tiong Kit Tan, Munawar Abbas, et al.NPJ Genomic Medicine|December 2, 2024
Hospital-wide access to genomic data advanced pediatric rare disease research and clinical outcomesCourtney E French, Nancy C Andrews, Alan H Beggs, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanomaR V Rawson, N G Maher, A M Menzies, et al.Nature Communications|April 17, 2020
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanomaAkash Mitra, Miles C Andrews, Whijae Roh, et al.Nature Communications|July 9, 2022
Multi-modal molecular programs regulate melanoma cell stateMiles C Andrews, Junna Oba, Chang-Jiun Wu, et al.The Lancet. Oncology|January 24, 2018
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trialRodabe N Amaria, Peter A Prieto, Michael T Tetzlaff, et al.Chemosphere|September 17, 2022
Quantitative assessment of visual microscopy as a tool for microplastic research: Recommendations for improving methods and reportingSyd Kotar, Rae McNeish, Clare Murphy-Hagan, et al.Nature Medicine|October 27, 2018
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaRodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.Pageof 133